SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3uhl'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4S_A_TPVA201_1
(PROTEIN (HIV-1
PROTEASE))		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
 None
 0.42A 1d4sA-3uhlA:
15.7		 1d4sA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
 None
 0.77A 1d4yA-3uhlA:
16.0		 1d4yA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  82
 None
 0.36A 1d4yA-3uhlA:
16.0		 1d4yA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
VAL A  82
 None
 0.44A 1fb7A-3uhlA:
16.1		 1fb7A-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
THR A  80
PRO A  81
VAL A  82
 None
 0.56A 1fb7A-3uhlA:
16.1		 1fb7A-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.54A 1hsgA-3uhlA:
15.9		 1hsgA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.37A 1hsgB-3uhlA:
16.1		 1hsgB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_1
(HIV-II PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.53A 1hshA-3uhlA:
16.4		 1hshA-3uhlA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASP A  25
GLY A  27
ASP A  29
PRO A  81
VAL A  82
 None
 0.56A 1hxwA-3uhlA:
16.3		 1hxwA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.72A 1hxwB-3uhlA:
15.7		 1hxwB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  84
 None
 0.40A 1k6cB-3uhlA:
16.1		 1k6cB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.60A 1muiA-3uhlA:
16.2		 1muiA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.62A 1muiB-3uhlA:
16.2		 1muiB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
VAL A  82
 None
 0.55A 1ohrA-3uhlA:
16.3		 1ohrA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_1
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.64A 1rl8A-3uhlA:
16.2		 1rl8A-3uhlA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_1
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.63A 1rl8A-3uhlA:
16.2		 1rl8A-3uhlA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.65A 1rl8B-3uhlA:
16.2		 1rl8B-3uhlA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.65A 1rl8B-3uhlA:
16.2		 1rl8B-3uhlA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.50A 1sdtB-3uhlA:
15.9		 1sdtB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.42A 1sduB-3uhlA:
16.3		 1sduB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.51A 1sdvB-3uhlA:
15.8		 1sdvB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SGU_B_MK1B2632_2
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.45A 1sguB-3uhlA:
16.7		 1sguB-3uhlA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.28A 1t3rA-3uhlA:
16.5		 1t3rA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.65A 1t3rB-3uhlA:
16.1		 1t3rB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.23A 1t7iA-3uhlA:
16.1		 1t7iA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  84
 None
 0.29A 1t7jA-3uhlA:
16.1		 1t7jA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOI_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 LEU A  23
ASP A  25
PRO A  81
VAL A  82
 None
 0.59A 2aoiB-3uhlA:
15.9		 2aoiB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOJ_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 LEU A  23
ASP A  25
PRO A  81
VAL A  82
 None
 0.54A 2aojA-3uhlA:
16.1		 2aojA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.65A 2aquA-3uhlA:
16.2		 2aquA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.57A 2aquA-3uhlA:
16.2		 2aquA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.66A 2aquB-3uhlA:
16.2		 2aquB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.59A 2aquB-3uhlA:
16.2		 2aquB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_2
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.45A 2avoB-3uhlA:
16.3		 2avoB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.36A 2avsB-3uhlA:
16.3		 2avsB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
 None
 0.28A 2avvA-3uhlA:
16.2		 2avvA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_3
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.48A 2avvB-3uhlA:
16.1		 2avvB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
 None
 0.53A 2avvD-3uhlA:
16.2		 2avvD-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.49A 2avvE-3uhlA:
16.1		 2avvE-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 1.13A 2b60A-3uhlA:
16.5		 2b60A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.56A 2b60A-3uhlA:
16.5		 2b60A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.42A 2b60B-3uhlA:
16.6		 2b60B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
 None
 0.40A 2b60B-3uhlA:
16.6		 2b60B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  84
 None
 0.55A 2b7zB-3uhlA:
16.5		 2b7zB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.51A 2bpxB-3uhlA:
15.9		 2bpxB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASN A  30
VAL A  82
 None
 0.62A 2f80A-3uhlA:
16.0		 2f80A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.46A 2f80A-3uhlA:
16.0		 2f80A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASN A  30
PRO A  81
VAL A  82
 None
 0.40A 2f80B-3uhlA:
16.0		 2f80B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_1
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.44A 2f81A-3uhlA:
16.1		 2f81A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.38A 2f81B-3uhlA:
16.0		 2f81B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.41A 2f8gA-3uhlA:
16.2		 2f8gA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_2
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.32A 2f8gB-3uhlA:
15.8		 2f8gB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_1
(POL PROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.65A 2fxdA-3uhlA:
15.8		 2fxdA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_1
(POL PROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  84
 None
 0.34A 2fxdA-3uhlA:
15.8		 2fxdA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 ARG A   8
ASP A  25
ALA A  28
ASP A  29
 None
 0.72A 2fxdB-3uhlA:
16.0		 2fxdB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_1
(POL PROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.64A 2fxeA-3uhlA:
16.0		 2fxeA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_1
(POL PROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.62A 2fxeA-3uhlA:
16.0		 2fxeA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.64A 2fxeB-3uhlA:
16.5		 2fxeB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.51A 2fxeB-3uhlA:
16.5		 2fxeB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.27A 2hs1A-3uhlA:
15.4		 2hs1A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
PRO A  81
VAL A  82
 None
 0.50A 2hs1B-3uhlA:
16.1		 2hs1B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_B_017B203_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 TRP A  42
PRO A  44
ARG A  57
GLY A  78
 None
 0.46A 2hs1B-3uhlA:
16.1		 2hs1B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.44A 2hs2A-3uhlA:
15.4		 2hs2A-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.42A 2hs2B-3uhlA:
16.1		 2hs2B-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_B_017B203_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 6 TRP A  42
PRO A  44
ARG A  57
GLY A  78
 None
 0.49A 2hs2B-3uhlA:
16.1		 2hs2B-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.25A 2idwB-3uhlA:
16.3		 2idwB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.50A 2ienA-3uhlA:
16.1		 2ienA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.26A 2ienB-3uhlA:
16.0		 2ienB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.73A 2ieoA-3uhlA:
16.1		 2ieoA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
VAL A  84
 None
 0.35A 2ieoB-3uhlA:
16.1		 2ieoB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.63A 2nmyA-3uhlA:
15.4		 2nmyA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.81A 2nmyA-3uhlA:
15.4		 2nmyA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
 None
 0.44A 2nmyA-3uhlA:
15.4		 2nmyA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
 None
 0.68A 2nmyA-3uhlA:
15.4		 2nmyA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
 None
 0.58A 2nmyB-3uhlA:
15.4		 2nmyB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_3
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
 None
 0.62A 2nmzB-3uhlA:
16.2		 2nmzB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_3
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
 None
 0.59A 2nmzB-3uhlA:
16.2		 2nmzB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
VAL A  84
 None
 0.25A 2nnkA-3uhlA:
15.9		 2nnkA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
PRO A  81
VAL A  82
VAL A  84
 None
 0.63A 2nnkA-3uhlA:
15.9		 2nnkA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  29
VAL A  84
 None
 0.68A 2nnkB-3uhlA:
16.0		 2nnkB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
PRO A  81
VAL A  82
VAL A  84
 None
 0.62A 2nnkB-3uhlA:
16.0		 2nnkB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
VAL A  82
 None
 0.72A 2nnpA-3uhlA:
15.9		 2nnpA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
VAL A  84
 None
 0.53A 2nnpB-3uhlA:
16.3		 2nnpB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
 None
 0.59A 2o4kA-3uhlA:
16.0		 2o4kA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.58A 2o4kB-3uhlA:
15.9		 2o4kB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.53A 2o4kB-3uhlA:
15.9		 2o4kB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.35A 2o4lA-3uhlA:
16.1		 2o4lA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4N_A_TPVA300_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
 None
 0.72A 2o4nA-3uhlA:
16.5		 2o4nA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4N_A_TPVA300_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.42A 2o4nA-3uhlA:
16.5		 2o4nA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
 None
 0.72A 2o4pA-3uhlA:
16.0		 2o4pA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.42A 2o4pA-3uhlA:
16.0		 2o4pA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.53A 2o4sA-3uhlA:
16.5		 2o4sA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.35A 2o4sB-3uhlA:
15.9		 2o4sB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.54A 2o4sB-3uhlA:
15.9		 2o4sB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASN A  30
PRO A  81
VAL A  82
 None
 0.51A 2pymA-3uhlA:
16.4		 2pymA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.51A 2pymB-3uhlA:
16.3		 2pymB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ASP A  29
ASN A  30
THR A  80
 None
 0.49A 2pymB-3uhlA:
16.3		 2pymB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASN A  30
PRO A  81
VAL A  82
 None
 0.54A 2pynA-3uhlA:
16.5		 2pynA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASN A  30
VAL A  82
 None
 0.23A 2pynB-3uhlA:
16.5		 2pynB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.65A 2pynB-3uhlA:
16.5		 2pynB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.50A 2q5kA-3uhlA:
16.2		 2q5kA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.63A 2q5kB-3uhlA:
16.1		 2q5kB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.50A 2q63B-3uhlA:
16.3		 2q63B-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_4
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ASP A  29
ASN A  30
THR A  80
 None
 0.43A 2q63B-3uhlA:
16.3		 2q63B-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_1
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASN A  30
PRO A  81
 None
 0.53A 2q64A-3uhlA:
16.2		 2q64A-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_3
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASN A  30
VAL A  82
 None
 0.29A 2q64B-3uhlA:
16.3		 2q64B-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_4
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.59A 2q64B-3uhlA:
16.3		 2q64B-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASN A  30
PRO A  81
 None
 0.51A 2qakA-3uhlA:
16.2		 2qakA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASN A  30
VAL A  82
 None
 0.33A 2qakB-3uhlA:
16.2		 2qakB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_4
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.65A 2qakB-3uhlA:
16.2		 2qakB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.57A 2qhcA-3uhlA:
16.3		 2qhcA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.53A 2qhcB-3uhlA:
16.0		 2qhcB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.49A 2r5pB-3uhlA:
16.3		 2r5pB-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.48A 2r5pD-3uhlA:
16.3		 2r5pD-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.49A 2r5qB-3uhlA:
16.0		 2r5qB-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.49A 2r5qD-3uhlA:
16.0		 2r5qD-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.48A 2rkfA-3uhlA:
16.1		 2rkfA-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_1
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.51A 2rkgA-3uhlA:
16.4		 2rkgA-3uhlA:
76.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
 None
 0.32A 2rkgB-3uhlA:
16.4		 2rkgB-3uhlA:
76.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.53A 2rkgB-3uhlA:
16.4		 2rkgB-3uhlA:
76.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.54A 2z54A-3uhlA:
16.2		 2z54A-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.54A 2z54B-3uhlA:
16.2		 2z54B-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_1
(PROTEASE
(RETROPEPSIN))		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.42A 3bvbA-3uhlA:
16.1		 3bvbA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.48A 3cywA-3uhlA:
15.9		 3cywA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.33A 3cywB-3uhlA:
16.0		 3cywB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.60A 3cyxA-3uhlA:
16.1		 3cyxA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.29A 3cyxA-3uhlA:
16.1		 3cyxA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
VAL A  82
 None
 0.75A 3d1xA-3uhlA:
16.2		 3d1xA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
 None
 0.58A 3d1xB-3uhlA:
16.0		 3d1xB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
 None
 0.21A 3d1xB-3uhlA:
16.0		 3d1xB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.50A 3d1xB-3uhlA:
16.0		 3d1xB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
VAL A  82
 None
 0.61A 3d1yA-3uhlA:
16.1		 3d1yA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.70A 3d1zA-3uhlA:
16.1		 3d1zA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.30A 3d1zB-3uhlA:
16.0		 3d1zB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.44A 3d20A-3uhlA:
16.3		 3d20A-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.27A 3d20B-3uhlA:
16.1		 3d20B-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 LEU A  23
ASP A  25
ALA A  28
ILE A  32
PRO A  81
 None
 0.58A 3ebzA-3uhlA:
16.5		 3ebzA-3uhlA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
 None
 0.35A 3ebzB-3uhlA:
16.6		 3ebzB-3uhlA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.59A 3ekqA-3uhlA:
15.9		 3ekqA-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.25A 3ektA-3uhlA:
16.3		 3ektA-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.28A 3ektC-3uhlA:
16.2		 3ektC-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.28A 3ektD-3uhlA:
16.2		 3ektD-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.21A 3ekvA-3uhlA:
16.1		 3ekvA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.58A 3ekwB-3uhlA:
15.8		 3ekwB-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.44A 3ekwB-3uhlA:
15.8		 3ekwB-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
 None
 0.68A 3ekxA-3uhlA:
15.8		 3ekxA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.54A 3ekyA-3uhlA:
16.1		 3ekyA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
 None
 0.51A 3el0A-3uhlA:
16.6		 3el0A-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.60A 3el1A-3uhlA:
15.9		 3el1A-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.36A 3el1A-3uhlA:
15.9		 3el1A-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.61A 3el1A-3uhlA:
15.9		 3el1A-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.61A 3el1B-3uhlA:
16.4		 3el1B-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
VAL A  84
 None
 0.66A 3el4A-3uhlA:
15.9		 3el4A-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
VAL A  84
 None
 0.59A 3el5B-3uhlA:
15.6		 3el5B-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 8 ARG A   8
ASP A  25
ALA A  28
ASP A  29
 None
 0.70A 3el9A-3uhlA:
15.6		 3el9A-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.68A 3el9B-3uhlA:
16.1		 3el9B-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.46A 3el9B-3uhlA:
16.1		 3el9B-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
 None
 0.33A 3em3A-3uhlA:
16.2		 3em3A-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.55A 3em3B-3uhlA:
16.2		 3em3B-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.70A 3em4A-3uhlA:
15.9		 3em4A-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.49A 3em4A-3uhlA:
15.9		 3em4A-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
VAL A  82
 None
 0.76A 3em4B-3uhlA:
16.0		 3em4B-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.58A 3em4B-3uhlA:
16.0		 3em4B-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.69A 3em4U-3uhlA:
16.2		 3em4U-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.51A 3em4U-3uhlA:
16.2		 3em4U-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ARG A   8
ASP A  25
ASP A  29
PRO A  81
VAL A  82
 None
 0.89A 3em4V-3uhlA:
16.1		 3em4V-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.48A 3em6B-3uhlA:
16.1		 3em6B-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  84
 None
 0.25A 3gguA-3uhlA:
16.6		 3gguA-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
GLY A  27
ALA A  28
PRO A  81
VAL A  84
 None
 0.50A 3gguA-3uhlA:
16.6		 3gguA-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.27A 3gguB-3uhlA:
16.6		 3gguB-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.40A 3jvyA-3uhlA:
16.0		 3jvyA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.22A 3jvyB-3uhlA:
16.0		 3jvyB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.25A 3k4vD-3uhlA:
16.0		 3k4vD-3uhlA:
80.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KW4_A_TICA600_1
(CYTOCHROME P450 2B4)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 THR A  89
ILE A  64
VAL A  15
VAL A  62
GLY A  73
 None
 0.91A 3kw4A-3uhlA:
undetectable		 3kw4A-3uhlA:
13.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.42A 3lzsA-3uhlA:
16.4		 3lzsA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.43A 3lzsB-3uhlA:
16.3		 3lzsB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.40A 3lzuA-3uhlA:
16.3		 3lzuA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASN A  30
VAL A  82
 None
 0.42A 3lzvA-3uhlA:
15.9		 3lzvA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.37A 3mwsA-3uhlA:
17.2		 3mwsA-3uhlA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.35A 3mwsB-3uhlA:
17.1		 3mwsB-3uhlA:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N3I_A_ROCA201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.19A 3n3iA-3uhlA:
11.4		 3n3iA-3uhlA:
38.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_3
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.58A 3ndtB-3uhlA:
16.1		 3ndtB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
 None
 0.56A 3ndtC-3uhlA:
16.2		 3ndtC-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
 None
 0.18A 3ndtC-3uhlA:
16.2		 3ndtC-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.59A 3ndtC-3uhlA:
16.2		 3ndtC-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.27A 3ndtD-3uhlA:
16.0		 3ndtD-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.57A 3nduA-3uhlA:
16.1		 3nduA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.24A 3nduA-3uhlA:
16.1		 3nduA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.51A 3nduB-3uhlA:
16.1		 3nduB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.26A 3nduD-3uhlA:
15.6		 3nduD-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.62A 3ndwA-3uhlA:
16.0		 3ndwA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
VAL A  82
 None
 0.76A 3ndwB-3uhlA:
16.1		 3ndwB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.63A 3ndxA-3uhlA:
16.0		 3ndxA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.59A 3ndxB-3uhlA:
16.3		 3ndxB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.38A 3ndxB-3uhlA:
16.3		 3ndxB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
 None
 0.24A 3nu3A-3uhlA:
16.1		 3nu3A-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.52A 3nu3A-3uhlA:
16.1		 3nu3A-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
 None
 0.39A 3nu3B-3uhlA:
16.0		 3nu3B-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASP A  25
ALA A  28
ILE A  32
PRO A  81
VAL A  82
 None
 0.69A 3nu4A-3uhlA:
16.1		 3nu4A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
 None
 0.25A 3nu4B-3uhlA:
16.1		 3nu4B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.52A 3nu5A-3uhlA:
16.0		 3nu5A-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
 None
 0.24A 3nu5B-3uhlA:
16.0		 3nu5B-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
 None
 0.29A 3nu6B-3uhlA:
16.1		 3nu6B-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 8 ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.72A 3nu9A-3uhlA:
15.8		 3nu9A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
VAL A  84
 None
 0.35A 3nu9B-3uhlA:
16.0		 3nu9B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OGQ_A_AB1A200_2
(FIV PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.33A 3ogqB-3uhlA:
14.7		 3ogqB-3uhlA:
33.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.26A 3oxcA-3uhlA:
15.5		 3oxcA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
 None
 0.53A 3oxcB-3uhlA:
16.0		 3oxcB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
 None
 0.17A 3oxcB-3uhlA:
16.0		 3oxcB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_A_478A200_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 6 TRP A  42
PRO A  44
ARG A  57
GLY A  78
 None
 0.63A 3oxvA-3uhlA:
16.5		 3oxvA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
 None
 0.20A 3oxvA-3uhlA:
16.5		 3oxvA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.35A 3oxwA-3uhlA:
16.4		 3oxwA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.33A 3oxwC-3uhlA:
16.6		 3oxwC-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.46A 3oxwD-3uhlA:
16.2		 3oxwD-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.58A 3oxxA-3uhlA:
15.9		 3oxxA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.39A 3oxxA-3uhlA:
15.9		 3oxxA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
VAL A  82
 None
 0.70A 3oxxB-3uhlA:
16.1		 3oxxB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.54A 3oxxB-3uhlA:
16.1		 3oxxB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.57A 3oxxC-3uhlA:
15.8		 3oxxC-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.48A 3oxxC-3uhlA:
15.8		 3oxxC-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.72A 3oxxD-3uhlA:
16.2		 3oxxD-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.71A 3oy4A-3uhlA:
15.6		 3oy4A-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.32A 3oy4B-3uhlA:
16.0		 3oy4B-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.39A 3pwmA-3uhlA:
16.1		 3pwmA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.33A 3pwmB-3uhlA:
16.0		 3pwmB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.64A 3pwrA-3uhlA:
15.9		 3pwrA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.29A 3pwrA-3uhlA:
15.9		 3pwrA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
 None
 0.52A 3pwrB-3uhlA:
15.9		 3pwrB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
 None
 0.19A 3pwrB-3uhlA:
15.9		 3pwrB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
 None
 0.25A 3s43B-3uhlA:
16.0		 3s43B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
 None
 0.38A 3s45B-3uhlA:
16.6		 3s45B-3uhlA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
 None
 0.23A 3s53A-3uhlA:
15.5		 3s53A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 LEU A  23
ASP A  25
ALA A  28
ILE A  32
PRO A  81
 None
 0.54A 3s53B-3uhlA:
16.0		 3s53B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_B_017B203_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 TRP A  42
PRO A  44
ARG A  57
GLY A  78
 None
 0.60A 3s53B-3uhlA:
16.0		 3s53B-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
 None
 0.34A 3s54A-3uhlA:
16.1		 3s54A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  29
ILE A  32
THR A  80
PRO A  81
 None
 0.62A 3s56A-3uhlA:
15.4		 3s56A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
THR A  80
 None
 0.39A 3s56A-3uhlA:
15.4		 3s56A-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.21A 3t3cA-3uhlA:
16.9		 3t3cA-3uhlA:
69.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.59A 3tkgA-3uhlA:
15.7		 3tkgA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.24A 3tkgA-3uhlA:
15.7		 3tkgA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
 None
 0.61A 3tkgB-3uhlA:
16.3		 3tkgB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.46A 3tkgB-3uhlA:
16.3		 3tkgB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
VAL A  82
 None
 0.41A 3tkgC-3uhlA:
15.5		 3tkgC-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
 None
 0.60A 3tkgD-3uhlA:
16.2		 3tkgD-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  82
 None
 0.17A 3tkgD-3uhlA:
16.2		 3tkgD-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_3
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.55A 3tkgD-3uhlA:
16.2		 3tkgD-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.28A 3tkwA-3uhlA:
16.1		 3tkwA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.41A 3ttpA-3uhlA:
16.9		 3ttpA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.39A 3ttpB-3uhlA:
16.8		 3ttpB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  84
 None
 0.27A 3u7sA-3uhlA:
16.9		 3u7sA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_2
(POL POLYPROTEIN)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  84
 None
 0.28A 3u7sB-3uhlA:
17.0		 3u7sB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASN A  30
ILE A  32
PRO A  81
VAL A  82
VAL A  84
 None
 0.35A 3ucbA-3uhlA:
17.4		 3ucbA-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
VAL A  82
VAL A  84
 None
 0.40A 3ucbB-3uhlA:
16.6		 3ucbB-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_B_017B202_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 TRP A  42
LYS A  55
GLY A  78
PRO A  79
 None
 1.25A 3ucbB-3uhlA:
16.6		 3ucbB-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_B_017B202_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 7 TRP A  42
PRO A  44
ARG A  57
GLY A  78
PRO A  79
 None
 0.58A 3ucbB-3uhlA:
16.6		 3ucbB-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_B_017B202_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 TRP A  42
PRO A  44
MET A  46
ARG A  57
 None
None
SO4  A 102 (-4.8A)
None
 1.05A 3ucbB-3uhlA:
16.6		 3ucbB-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASN A  30
THR A  80
PRO A  81
 None
 0.49A 3ufnA-3uhlA:
17.1		 3ufnA-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 ARG A   8
ASP A  25
VAL A  82
VAL A  84
 None
 0.52A 3ufnB-3uhlA:
16.4		 3ufnB-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA402_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 ARG A   8
LEU A  23
PRO A  81
VAL A  82
 None
 0.62A 3ufnA-3uhlA:
17.1
3ufnB-3uhlA:
16.4		 3ufnA-3uhlA:
100.00
3ufnB-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.68A 4dqbA-3uhlA:
15.9		 4dqbA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.38A 4dqbB-3uhlA:
16.3		 4dqbB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.26A 4dqcB-3uhlA:
16.1		 4dqcB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.57A 4dqeA-3uhlA:
15.9		 4dqeA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.36A 4dqeB-3uhlA:
16.3		 4dqeB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_1
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.41A 4dqfA-3uhlA:
14.8		 4dqfA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_2
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.36A 4dqfB-3uhlA:
16.3		 4dqfB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.65A 4dqhA-3uhlA:
15.9		 4dqhA-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.34A 4dqhB-3uhlA:
16.3		 4dqhB-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.45A 4hlaA-3uhlA:
16.3		 4hlaA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.48A 4hlaB-3uhlA:
16.3		 4hlaB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4J5J_B_478B401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ASP A  25
ALA A  28
ASN A  30
ILE A  32
VAL A  82
VAL A  84
 None
 0.65A 4j5jB-3uhlA:
16.5		 4j5jB-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4J5J_B_478B401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ASP A  25
ALA A  28
ILE A  32
PRO A  81
VAL A  82
VAL A  84
 None
 0.51A 4j5jB-3uhlA:
16.5		 4j5jB-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4J5J_B_478B402_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 TRP A  42
PRO A  44
ARG A  57
PRO A  79
 None
 0.62A 4j5jB-3uhlA:
16.5		 4j5jB-3uhlA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  84
 None
 0.70A 4l1aA-3uhlA:
16.4		 4l1aA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
VAL A  84
 None
 0.39A 4l1aA-3uhlA:
16.4		 4l1aA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.25A 4ll3B-3uhlA:
16.3		 4ll3B-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.27A 4ll3A-3uhlA:
16.3		 4ll3A-3uhlA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.24A 4njtB-3uhlA:
16.5		 4njtB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.26A 4njtD-3uhlA:
16.4		 4njtD-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
 None
 0.77A 4njuA-3uhlA:
15.9		 4njuA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
 None
 0.47A 4njuA-3uhlA:
15.9		 4njuA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
 None
 0.79A 4njuC-3uhlA:
15.9		 4njuC-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
 None
 0.47A 4njuC-3uhlA:
15.9		 4njuC-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
 None
 0.46A 4njvA-3uhlA:
15.9		 4njvA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASP A  25
GLY A  27
ASP A  29
PRO A  81
 None
 0.78A 4njvC-3uhlA:
16.0		 4njvC-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.33A 4q1wA-3uhlA:
16.2		 4q1wA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_1
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
VAL A  82
 None
 0.35A 4q1xA-3uhlA:
16.3		 4q1xA-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_2
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ILE A  32
PRO A  81
VAL A  82
 None
 0.77A 4q1xB-3uhlA:
15.9		 4q1xB-3uhlA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
VAL A  82
 None
 0.33A 4q1yA-3uhlA:
16.4		 4q1yA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ILE A  32
PRO A  81
VAL A  82
 None
 0.55A 4q1yB-3uhlA:
16.0		 4q1yB-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q5M_A_ROCA1101_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ASP A  29
ASN A  30
THR A  80
PRO A  81
VAL A  82
 None
 0.58A 4q5mA-3uhlA:
13.8		 4q5mA-3uhlA:
39.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
THR A  80
VAL A  82
 None
 0.40A 4qgiA-3uhlA:
15.9		 4qgiA-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  82
 None
 0.54A 4qgiB-3uhlA:
16.0		 4qgiB-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 LEU A  23
ASP A  25
ALA A  28
PRO A  81
VAL A  82
 None
 0.55A 4qgiB-3uhlA:
16.0		 4qgiB-3uhlA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4YOA_A_017A100_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 6 ASP A  29
THR A  80
PRO A  81
VAL A  84
 None
 0.59A 4yoaA-3uhlA:
17.5		 4yoaA-3uhlA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
 None
 0.25A 5e5jA-3uhlA:
16.1		 5e5jA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
PRO A  81
 None
 0.52A 5e5jB-3uhlA:
16.1		 5e5jB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.29A 5e5kA-3uhlA:
16.1		 5e5kA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.47A 5e5kB-3uhlA:
16.1		 5e5kB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_1
(PROTEASE E35D-SQV)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
THR A  80
PRO A  81
VAL A  82
 None
 0.72A 5kqxA-3uhlA:
15.9		 5kqxA-3uhlA:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.45A 5t2zA-3uhlA:
16.5		 5t2zA-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.28A 5t2zB-3uhlA:
16.4		 5t2zB-3uhlA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.29A 5t8hA-3uhlA:
16.1		 5t8hA-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_2
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
PRO A  81
 None
 0.53A 5t8hB-3uhlA:
16.1		 5t8hB-3uhlA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.32A 6dgxA-3uhlA:
16.4		 6dgxA-3uhlA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
LEU A  76
PRO A  81
VAL A  82
 None
 0.54A 6dgxB-3uhlA:
15.9		 6dgxB-3uhlA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_0
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
VAL A  84
 None
 0.37A 6dh0A-3uhlA:
16.5		 6dh0A-3uhlA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
LEU A  76
PRO A  81
VAL A  82
VAL A  84
 None
 0.68A 6dh0B-3uhlA:
16.0		 6dh0B-3uhlA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.27A 6dh3A-3uhlA:
16.4		 6dh3A-3uhlA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
 None
 0.38A 6dh3B-3uhlA:
15.8		 6dh3B-3uhlA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_0
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  82
 None
 0.32A 6dh6A-3uhlA:
16.3		 6dh6A-3uhlA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
LEU A  76
PRO A  81
 None
 0.56A 6dh6B-3uhlA:
15.9		 6dh6B-3uhlA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.37A 6difA-3uhlA:
16.0		 6difA-3uhlA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.27A 6difB-3uhlA:
15.9		 6difB-3uhlA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
 None
 0.74A 6dilA-3uhlA:
15.9		 6dilA-3uhlA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.45A 6dilA-3uhlA:
15.9		 6dilA-3uhlA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
 None
 0.75A 6dilB-3uhlA:
16.0		 6dilB-3uhlA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
PRO A  81
VAL A  82
 None
 0.41A 6dilB-3uhlA:
16.0		 6dilB-3uhlA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.47A 6dj1A-3uhlA:
16.3		 6dj1A-3uhlA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.61A 6dj1B-3uhlA:
15.9		 6dj1B-3uhlA:
81.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ASP A  25
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.56A 6dj2A-3uhlA:
16.3		 6dj2A-3uhlA:
80.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 3uhl PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
 None
 0.65A 6dj2B-3uhlA:
15.8		 6dj2B-3uhlA:
80.00